Cargando…

Immunosuppressants: COVID-19 respiratory infections: 16 case reports

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119600/ http://dx.doi.org/10.1007/s40278-021-95859-2

Ejemplares similares

Immunosuppressants: COVID-19 infection: case report
Publicado: (2022)

Immunosuppressants: COVID-19 infection: 20 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 10 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 2 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 4 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 4 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 7 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 52 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 3 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 infection: 18 case reports
Publicado: (2020)

Immunosuppressants: COVID-19 infection and cytomegalovirus infection: 5 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 and secondary infections: 3 case reports
Publicado: (2020)

Immunosuppressants: COVID-19: case report
Publicado: (2020)

Immunosuppressants: Co-infection of COVID-19 with dengue fever: case report
Publicado: (2021)

Immunosuppressants: COVID-19 infection, myelosuppression and febrile neutropenia: case report.
Publicado: (2020)

Immunosuppressants: COVID-19 infection, COVID-19 pneumonia and nosocomial bacterial infection: 2 case reports
Publicado: (2020)

Immunosuppressants: COVID-19 pneumonia: case report
Publicado: (2021)

Immunosuppressants: COVID-19: 11 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 reinfection: case report
Publicado: (2021)

Immunosuppressants: COVID-19: 11 case reports
Publicado: (2021)

Immunosuppressants: COVID-19: 5 case reports
Publicado: (2020)

Immunosuppressants: COVID-19: 5 case reports
Publicado: (2020)

Immunosuppressants: COVID-19 reactivation: case report
Publicado: (2022)

Immunosuppressants: Severe acute respiratory syndrome coronavirus-2 infection: case report
Publicado: (2021)

Immunosuppressants/mRNA-1273/remdesivir: COVID-19 respiratory infection, acute kidney injury and lack of efficacy: case report
Publicado: (2021)

Immunosuppressants: COVID-2019 infections: 7 case reports
Publicado: (2020)

Immunosuppressants: COVID-2019 infection: 13 case reports
Publicado: (2020)

Immunosuppressants/CAR T-cell therapies: COVID-19 infection: 2 case reports
Publicado: (2020)

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)

Immunosuppressants: COVID-19, Cytomegalovirus reactivation and Pseudomonas infection: 4 case reports
Publicado: (2022)

Immunosuppressants: COVID-19 and COVID-19-pneumonia: 19 case reports
Publicado: (2021)

Immunosuppressants: Severe acute respiratory syndrome coronavirus-2 infection: 4 case reports
Publicado: (2021)

Eculizumab/immunosuppressants: Severe acute respiratory syndrome coronavirus-2 infection: case report
Publicado: (2021)

Immunosuppressants: COVID-19 pneumonia: 6 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 pneumonia: 10 case reports
Publicado: (2020)

Immunosuppressants: COVID-19-pneumonia: 2 case reports
Publicado: (2020)

Immunosuppressant: COVID-19 pneumonia: 2 case reports
Publicado: (2020)

Immunosuppressants: COVID-19 infection and posterior reversible encephalopathy syndrome: 9 case reports
Publicado: (2022)

Immunosuppressants: Severe acute respiratory syndrome coronavirus-2 infection and lymphopenia: 2 case reports
Publicado: (2021)

Immunosuppressants: COVID-19 pneumonia and colitis: 6 case reports
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d6hdvio1vnb75tre7duivjtd40